Rockefeller Plaza display underscores Lighthouse International’s vision loss programs

Article

See Lighthouse International's current advertising campaign, "Will I be able to read?", in a display window at Rockefeller Center.

 

New York-”Will I be able to read?” is the question that someone diagnosed with macular degeneration, glaucoma, retinitis pigmentosa, or other eye diseases always asks.

“Will I Be Able to Read?” also is the title of Lighthouse International’s current advertising campaign, which is showcased in a display window in Rockefeller Center. EHE International, a leader in preventive healthcare, donated the display space. The 180” x 83” display will be in Rockefeller Plaza through January 31.

Said Deborah McKeever, president of EHE International, “Together we hope to enlighten, inform and raise awareness about vision loss and empower those living with vision loss and their caregivers through the resources available at Lighthouse International.”

The ad campaign’s focus is to let individuals with vision loss, as well as their families, caregivers, and loved ones, know that there is help, hope, and resources available to enhance their quality of life and enable them to live safely and independently. Lighthouse International offers services and programs that help people of all ages overcome the challenges of vision loss.

 

Read more articles from this week's News Flash.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dana Shannon, OD, FAAO, shares pearls on spotting red flags in need of referral and enhancing patient care with follow-up compliance.
Dana Shannon, OD, FAAO, detailed a lecture she gave at the NOA Midwestern Symposium earlier this month.
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
Dr. Nate Lighthizer shares key takeaways from the SECO Showcase on anterior segment technology and full laser certification course offered at SECO.
Shan Lin, MD, and John Berdahl, MD, share their perspectives as ophthalmologists regarding the importance of comanagement.
Robert L. Stamper, MD, overviews his optometric track talk titled Objective Perimetry - Can you see it? at this year's Glaucoma 360 meeting.
Yvonne Ou, MD, outlined lifestyle modifications for glaucoma management that have proven beneficial, including yoga and cycling.
© 2025 MJH Life Sciences

All rights reserved.